logo
logo
Sign in

Blood Screening Market To Represent CAGR Exceeding 9.5% By 2023 | Key Players, SWOT Analysis, Emerging Trends, Dynamics and Segmentation

avatar
rahul kumar
Blood Screening Market To Represent CAGR Exceeding 9.5% By 2023 | Key Players, SWOT Analysis, Emerging Trends, Dynamics and Segmentation

Jul 22, 2019 (AB Digital via COMTEX) -- The Global Blood Screening Market is expected to register a growth of significant CAGR 9.8% during the forecast period (2018–2023).

The global blood screening market has been segmented on the devices, service providers, application, end users.

The nucleic acid amplification test is segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR).

Based on products and services, the blood screening market has been classified as reagent and kits, enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides, and solutions, immunosorbents, instruments and software and services.

U.S. blood screening market dominated industry in 2017, due to the high demand for quality healthcare, vastly developed healthcare infrastructure as well as growing occurrence of cardiac disease in the region.

Frequencies of blood screening are dramatically increasing over the last few years.

collect
0
avatar
rahul kumar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more